Aurora Cannabis (ACB) Current Assets (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Current Assets of $289.8 million for Q1 2026, down 13.06% year-on-year from $333.4 million in Q1 2025, and down 13.06% on a QoQ basis from $333.4 million in Q1 2025.
Aurora Cannabis (ACB) Current Assets (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Current Assets for 9 consecutive years, with $289.8 million the latest figure, recorded in Q1 2026.
- Quarterly Current Assets fell 13.06% year-over-year to $289.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $289.8 million (down 13.06% YoY) and the FY2026 annual result came in at $287.6 million, down 16.42% from the prior year.
- Current Assets declined to $289.8 million in Q1 2026 per ACB's latest filing, from $333.4 million in the prior quarter.
- Over the last five years, Current Assets for ACB reached as high as $584.4 million in Q2 2022 and fell as low as $289.8 million in Q1 2026.
- A 5-year average of $356.7 million and a median of $326.7 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets increased 7.88% — and 2026, when it fell 13.06%.
- Year by year, Current Assets stood at $584.4 million in 2022, then plunged by 39.26% to $355.0 million in 2023, then retreated by 1.49% to $349.7 million in 2024, then slipped by 4.68% to $333.4 million in 2025, then declined by 13.06% to $289.8 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $289.8 million, $333.4 million, and $349.7 million for Q1 2026, Q1 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 289.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 289.82 Mn |
| Mar 31, 2025 | 333.35 Mn |
| Dec 31, 2024 | 349.73 Mn |
| Sep 30, 2024 | 305.00 Mn |
| Jun 30, 2024 | 320.05 Mn |
| Mar 31, 2024 | 316.59 Mn |
| Mar 31, 2023 | 355.00 Mn |
| Jun 30, 2022 | 584.43 Mn |
| Jun 30, 2021 | 541.72 Mn |
| Jun 30, 2020 | 301.11 Mn |
| Jun 30, 2019 | 493.72 Mn |
| Jun 30, 2018 | 170.30 Mn |